Living in Balance
We at Alliance Hematology Oncology believe that finding or maintaining balance is especially crucial when a person is faced with health-related challenges. In finding this balance, we are able to free up time and energy to focus on being fully present in each moment.
Our physicians, nurses and support staff have developed a model of care that provides patients with state-of-the-art treatments, clinical trials, emotional support and comfortable, convenient surroundings that are necessary to ensure balance and quality of life.
Latest Cancer News
Rectal Cancer Increasing in People Under 40
(09-2-2010)
Although still relatively uncommon in young people, the incidence of rectal cancer appears to be increasing in this population. These results were published in the journal Cancer. Colorectal cancer is... Continue Reading
Early Palliative Care Linked with Longer Lung Cancer Survival (09-1-2010)
Palliative care is care that is focused on symptom management, psychosocial issues, decision-making, and quality of life. Among patients with newly diagnosed, metastatic, non-small cell lung cancer, the... Continue Reading
Istodax Active against Refractory Cutaneous T-cell Lymphoma (08-31-2010)
Final results from a Phase II clinical trial provide additional evidence that Istodax® (romidepsin) is active against refractory cutaneous T-cell lymphoma. These results were published in the Journal... Continue Reading
Although still relatively uncommon in young people, the incidence of rectal cancer appears to be increasing in this population. These results were published in the journal Cancer. Colorectal cancer is... Continue Reading
Early Palliative Care Linked with Longer Lung Cancer Survival (09-1-2010)
Palliative care is care that is focused on symptom management, psychosocial issues, decision-making, and quality of life. Among patients with newly diagnosed, metastatic, non-small cell lung cancer, the... Continue Reading
Istodax Active against Refractory Cutaneous T-cell Lymphoma (08-31-2010)
Final results from a Phase II clinical trial provide additional evidence that Istodax® (romidepsin) is active against refractory cutaneous T-cell lymphoma. These results were published in the Journal... Continue Reading
More Cancer News
Types of Cancer
More Cancer Types
United in Healing
